


KeifeRx
Biotechnology Research • McLean, Virginia, United States • 1-10 Employees
Company overview
| Headquarters | 1356 Beverly Rd, 300, McLean, Virginia 22101, US |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Founded | 2019 |
| Employees | 1-10 |
| Socials |
Key Contacts at KeifeRx
Chris Hoyt
Chief Executive Officer
Fernando Pagan
Co-Founder And Board Member
KeifeRx Email Formats
KeifeRx uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@keiferx.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@keiferx.com | 100% |
About KeifeRx
KeifeRx is an emerging clinical-stage biopharmaceutical company developing novel and optimized, low dose, orally delivered tyrosine kinase inhibitors (TKIs) for the treatment of multiple, high-need neurodegenerative and immune diseases.
KeifeRx revenue & valuation
| Annual revenue | $598,885 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,000,000 |
| Total funding | $6,000,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
KeifeRx has 3 employees across 3 departments.
Departments
Number of employees
KeifeRx Tech Stack
Discover the technologies and tools that power KeifeRx's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Reverse proxies
Miscellaneous
Frequently asked questions
4.8
40,000 users



